scispace - formally typeset
Journal ArticleDOI

mTOR complexes in neurodevelopmental and neuropsychiatric disorders

Mauro Costa-Mattioli, +1 more
- 01 Nov 2013 - 
- Vol. 16, Iss: 11, pp 1537-1543
Reads0
Chats0
TLDR
The most recent advances in studies of mTOR signaling in the brain and the possible mechanisms underlying the many different functions of the mTOR complexes in neurological diseases are described and the medical relevance is discussed.
Abstract
The mechanistic target of rapamycin (mTOR) acts as a highly conserved signaling "hub" that integrates neuronal activity and a variety of synaptic inputs. mTOR is found in two functionally distinct complexes, mTORC1 and mTORC2, that crucially control long-term synaptic efficacy and memory storage. Dysregulation of mTOR signaling is associated with neurodevelopmental and neuropsychiatric disorders. In this Review, we describe the most recent advances in studies of mTOR signaling in the brain and the possible mechanisms underlying the many different functions of the mTOR complexes in neurological diseases. In addition, we discuss the medical relevance of these findings.

read more

Citations
More filters
Journal ArticleDOI

Neurobiology of addiction: A neurocircuitry analysis.

TL;DR: Molecular genetic studies have identified transduction and transcription factors that act in neurocircuitry associated with the development and maintenance of addiction that might mediate initial vulnerability, maintenance, and relapse associated with addiction.
Journal ArticleDOI

BDNF - a key transducer of antidepressant effects.

TL;DR: Current data suggests that conventional antidepressants and ketamine mediate their antidepressant-like effects by increasing BDNF in forebrain regions, in particular the hippocampus, making BDNF an essential determinant of antidepressant efficacy.
Journal ArticleDOI

Immune mediators in the brain and peripheral tissues in autism spectrum disorder

TL;DR: Findings indicate that the immune system is a point of convergence for multiple ASD-related genetic and environmental risk factors.
Journal ArticleDOI

Translational Control in Synaptic Plasticity and Cognitive Dysfunction

TL;DR: This review discusses the key regulatory pathways that govern translational control in response to synaptic activity and the mRNA populations that are specifically targeted by these pathways and considers the therapeutic potential of targeting dysregulated translatory control to treat cognitive disorders of synaptic dysfunction.
Journal ArticleDOI

mTOR in Brain Physiology and Pathologies

TL;DR: Preclinical and preliminary clinical studies indicate that inhibition of mTORC1 can be beneficial for some pathological conditions such as epilepsy, cognitive impairment, and brain tumors, whereas stimulation of m TORC1 (direct or indirect) can bebeneficial for other pathologies such as depression or axonal growth and regeneration.
References
More filters
Journal ArticleDOI

Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.

TL;DR: The present result suggests that the blockade of the mGlu2/3 receptor may activate mTOR signaling, and that the activation of m TOR signaling may contribute to the sustained antidepressant-like effects of mGLU2/ 3 receptor antagonists.
Journal ArticleDOI

TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase

TL;DR: It is found that T SC2 modulates actin dynamics and cell adhesion and the TSC1-binding domain (TSC2-HBD) is essential for this function of TSC2.
Journal ArticleDOI

Dysregulation of synaptic plasticity precedes appearance of morphological defects in a Pten conditional knockout mouse model of autism.

TL;DR: The results reveal that deletion of Pten in dentate granule cells dysregulates synaptic plasticity, a defect that may underlie abnormal social and cognitive behaviors observed in humans with inactivating mutations and potentially other autism spectrum disorders.
Journal ArticleDOI

Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS-Pten conditional knockout mice

TL;DR: Evaluated the efficacy of an intermittent rapamycin treatment protocol on epilepsy progression using neuron subset‐specific‐Pten (NS‐ Pten) conditional knockout mice.
Related Papers (5)